PMID- 19132893 OWN - NLM STAT- MEDLINE DCOM- 20090916 LR - 20131121 IS - 1937-335X (Electronic) IS - 1937-3341 (Linking) VI - 15 IP - 7 DP - 2009 Jul TI - In vivo osteogenic differentiation of human adipose-derived stem cells in an injectable in situ-forming gel scaffold. PG - 1821-32 LID - 10.1089/ten.tea.2008.0386 [doi] AB - The sol-to-gel transition occurring at around body temperature makes the MPEG-PCL diblock copolymer an ideal candidate material for use as an injectable in situ-forming gel containing human adipose tissue-derived stem cells (hADSCs). The sol can be prepared at room temperature, and the gel forms at body temperature. Solutions of the copolymer containing hADSCs and osteogenic factors injected into rats formed gel scaffolds at the injection sites. The gels thus formed showed the interconnective pore structure required to support growth, proliferation, and differentiation of hADSCs. Bromodeoxyuridine-labeled hADSCs were confirmed to be present in gels formed in vivo. Bone formation was observed only in gel implants containing both hADSCs and osteogenic factors. Subcutaneous implantation of the in situ-forming gel scaffold demonstrated that hADSCs embedded in the gel stimulated much lower host tissue responses than did the gel alone, probably because of the unique immunomodulatory properties of hADSCs. In conclusion, our data on hADSCs embedded in an in situ gel scaffold suggest that this formulation may provide numerous benefits as a noninvasive alternative for tissue-engineered bone formation. FAU - Ahn, Hyun Hee AU - Ahn HH AD - Fusion Biotechnology Research Center, Korea Research Institute of Chemical Technology, Daejeon, Korea. FAU - Kim, Kyung Sook AU - Kim KS FAU - Lee, Jung Hwa AU - Lee JH FAU - Lee, Ju Young AU - Lee JY FAU - Kim, Byung Soo AU - Kim BS FAU - Lee, Il Woo AU - Lee IW FAU - Chun, Heung Jae AU - Chun HJ FAU - Kim, Jae Ho AU - Kim JH FAU - Lee, Hai Bang AU - Lee HB FAU - Kim, Moon Suk AU - Kim MS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Tissue Eng Part A JT - Tissue engineering. Part A JID - 101466659 RN - 0 (Gels) RN - G34N38R2N1 (Bromodeoxyuridine) SB - IM MH - Adipocytes/*cytology MH - Animals MH - Bromodeoxyuridine/metabolism MH - Cell Adhesion MH - *Cell Differentiation MH - Cell Survival MH - Female MH - Fluorescent Antibody Technique MH - Gels MH - Humans MH - Inflammation MH - Injections MH - Injections, Subcutaneous MH - *Osteogenesis MH - Rats MH - Rats, Inbred F344 MH - Staining and Labeling MH - Stem Cells/*cytology/ultrastructure MH - Temperature MH - *Tissue Scaffolds MH - Viscosity EDAT- 2009/01/10 09:00 MHDA- 2009/09/17 06:00 CRDT- 2009/01/10 09:00 PHST- 2009/01/10 09:00 [entrez] PHST- 2009/01/10 09:00 [pubmed] PHST- 2009/09/17 06:00 [medline] AID - 10.1089/ten.tea.2008.0386 [doi] PST - ppublish SO - Tissue Eng Part A. 2009 Jul;15(7):1821-32. doi: 10.1089/ten.tea.2008.0386.